Skip to main content
Equibles

Palo Alto Investors LP

Position in NUVB — Nuvation Bio Inc.

CIK 1306923 PALO ALTO, CA
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$1,855,139
-$327,810 QoQ
Shares Held
326,609
-35.8% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#66
of 242 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Palo Alto Investors LP holds $594,195,112 across 39 Biotechnology names. NUVB ranks #30 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PTCT
Ptc Therapeutics, Inc.
 918,846 $74,950,268
2 ACAD
Acadia Pharmaceuticals Inc
 2,864,096 $72,461,628
3 INSM
INSMED Inc
 413,980 $44,138,547
4 MIRM
Mirum Pharmaceuticals, Inc.
 348,808 $40,834,952
5 ANAB
Anaptysbio, Inc
 603,489 $40,735,507
6 BMRN
Biomarin Pharmaceutical Inc
 682,777 $39,068,499
7 DYN
Dyne Therapeutics, Inc.
 1,647,521 $36,591,441
8 IRON
Disc Medicine, Inc.
 416,646 $30,473,488

All Filings in NUVB

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,855,139 326,609
2026-03-31 $2,182,949 508,846
2025-12-31 $4,821,187 538,079
2025-09-30 $3,776,023 1,020,547
2025-06-30 $1,506,671 772,652
2025-03-31 $1,359,867 772,652
2024-12-31 $2,055,254 772,652
2024-09-30 $1,769,373 772,652
2024-06-30 $2,256,143 772,652
2024-03-31 $2,812,453 772,652